Aaron B. Lerner Lectureship Series

Background

Aaron Lerner received his MD, Ph.D. degree from the University and went on to an outstanding research and teaching career at the Yale School of Medicine specializing in the metabolic basis of inherited disease, specifically vitilego.

The focus on this seminar series is on the linkage between human disease and biochemical mechanisms.


Dr. Karen Ashe
University of Minnesota, Twin Cities
Department of Neurology

 

Tuesday, November 17th, 2009
12:20 PM in Mayo Auditorium
Minneapolis Campus

"Human relevance of a common Alzheimer mourse model."


Archive

YearSpeaker/AffiliationTitle
2008
Dr. Berhnhard Hering, Dept. Surgery, University of Minnesota Transformative Therapeutics to Cure Type 1 Diabetes.
2007
Dr. Harry "Chip" Davis, Schering-Plough Research Institute, Kenilworth, NJZetia (Ezetimibe): Inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to Reduce Intestinal Cholesterol Absorption and Treat Hyperlipidemia.
2006
Dr. Michael Jensen
Mayo Clinic, Rochester, MN
Role of Adipose Tissue Fatty Acid Release in Human Metabolic Disease.
2005
Dr. Arnold W. Strauss, MD
Vanderbilt University, Nashville, TN
Cancelled
2004
Dr. Jean Schaffer
Washington Univeristy School of Medicine, St. Louis, MO
Lipotoxicity: when tissues overeat.
2003
Dr. Paul Watkins
Johns Hopkins School of Medicine, Baltimore, MD
X-linked Adrenoleukodystrophy: Is there a problem with 'Bubblegum" in the Brain?
2002
Dr. Vincent J. Hearing
National Cancer Institute, Bethesda, MD
Mechanisms of Hypopigmentation in Human Hypopigmentary Diseases.